Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean
- Autores
- Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; Dookeeram, Darren K.; Marin, Danini; Giangreco, Lucia; Lichtenberger, Paola; Marin, Gustavo Horacio
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.
Fil: Nagassar, Rajeev P.. No especifíca;
Fil: Jalim, Narin. No especifíca;
Fil: Mitchell, Arianne. No especifíca;
Fil: Harrinanan, Ashley. No especifíca;
Fil: Mohammed, Anisa. No especifíca;
Fil: Dookeeram, Darren K.. No especifíca;
Fil: Marin, Danini. No especifíca;
Fil: Giangreco, Lucia. No especifíca;
Fil: Lichtenberger, Paola. No especifíca;
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina - Materia
-
ANTIBIOTIC CONSUMPTION
ANTIBIOTIC CONSUMPTION
ANTIBIOTICS
ATC CLASSIFICATION
AWARE
CARIBBEAN
COVID-19
DDD
DDD PER 1000 INHABITANTS PER DAY
PANDEMIC
TRINIDAD AND TOBAGO - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/222971
Ver los metadatos del registro completo
id |
CONICETDig_3cbefeeb44116a8465f7f4556e830ded |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/222971 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking CaribbeanNagassar, Rajeev P.Jalim, NarinMitchell, ArianneHarrinanan, AshleyMohammed, AnisaDookeeram, Darren K.Marin, DaniniGiangreco, LuciaLichtenberger, PaolaMarin, Gustavo HoracioANTIBIOTIC CONSUMPTIONANTIBIOTIC CONSUMPTIONANTIBIOTICSATC CLASSIFICATIONAWARECARIBBEANCOVID-19DDDDDD PER 1000 INHABITANTS PER DAYPANDEMICTRINIDAD AND TOBAGOhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020.Fil: Nagassar, Rajeev P.. No especifíca;Fil: Jalim, Narin. No especifíca;Fil: Mitchell, Arianne. No especifíca;Fil: Harrinanan, Ashley. No especifíca;Fil: Mohammed, Anisa. No especifíca;Fil: Dookeeram, Darren K.. No especifíca;Fil: Marin, Danini. No especifíca;Fil: Giangreco, Lucia. No especifíca;Fil: Lichtenberger, Paola. No especifíca;Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; ArgentinaMDPI2023-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/222971Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-122079-6382CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/antibiotics12030466info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:52:49Zoai:ri.conicet.gov.ar:11336/222971instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:52:50.02CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
title |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
spellingShingle |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean Nagassar, Rajeev P. ANTIBIOTIC CONSUMPTION ANTIBIOTIC CONSUMPTION ANTIBIOTICS ATC CLASSIFICATION AWARE CARIBBEAN COVID-19 DDD DDD PER 1000 INHABITANTS PER DAY PANDEMIC TRINIDAD AND TOBAGO |
title_short |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
title_full |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
title_fullStr |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
title_full_unstemmed |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
title_sort |
Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean |
dc.creator.none.fl_str_mv |
Nagassar, Rajeev P. Jalim, Narin Mitchell, Arianne Harrinanan, Ashley Mohammed, Anisa Dookeeram, Darren K. Marin, Danini Giangreco, Lucia Lichtenberger, Paola Marin, Gustavo Horacio |
author |
Nagassar, Rajeev P. |
author_facet |
Nagassar, Rajeev P. Jalim, Narin Mitchell, Arianne Harrinanan, Ashley Mohammed, Anisa Dookeeram, Darren K. Marin, Danini Giangreco, Lucia Lichtenberger, Paola Marin, Gustavo Horacio |
author_role |
author |
author2 |
Jalim, Narin Mitchell, Arianne Harrinanan, Ashley Mohammed, Anisa Dookeeram, Darren K. Marin, Danini Giangreco, Lucia Lichtenberger, Paola Marin, Gustavo Horacio |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
ANTIBIOTIC CONSUMPTION ANTIBIOTIC CONSUMPTION ANTIBIOTICS ATC CLASSIFICATION AWARE CARIBBEAN COVID-19 DDD DDD PER 1000 INHABITANTS PER DAY PANDEMIC TRINIDAD AND TOBAGO |
topic |
ANTIBIOTIC CONSUMPTION ANTIBIOTIC CONSUMPTION ANTIBIOTICS ATC CLASSIFICATION AWARE CARIBBEAN COVID-19 DDD DDD PER 1000 INHABITANTS PER DAY PANDEMIC TRINIDAD AND TOBAGO |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020. Fil: Nagassar, Rajeev P.. No especifíca; Fil: Jalim, Narin. No especifíca; Fil: Mitchell, Arianne. No especifíca; Fil: Harrinanan, Ashley. No especifíca; Fil: Mohammed, Anisa. No especifíca; Fil: Dookeeram, Darren K.. No especifíca; Fil: Marin, Danini. No especifíca; Fil: Giangreco, Lucia. No especifíca; Fil: Lichtenberger, Paola. No especifíca; Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina |
description |
An antimicrobial consumption (AMC) study was performed in Trinidad and Tobago at the Eastern Regional Health Authority (ERHA). A retrospective, cross-sectional survey was conducted from 1 November 2021 to 30 March 2022. Dosage and package types of amoxicillin, azithromycin, co-amoxiclav, cefuroxime, ciprofloxacin, levofloxacin, moxifloxacin, nitrofurantoin and co-trimoxazole were investigated. Consumption was measured using the World Health Organization’s Antimicrobial Resistance and Consumption Surveillance System methodology version 1.0, as defined daily doses (DDD) per 1000 population per day (DID). They were also analyzed using the ‘Access’, ‘Watch’ and ‘Reserve’ classifications. In the ERHA, AMC ranged from 6.9 DID to 4.6 DID. With regards to intravenous formulations, the ‘Watch’ group displayed increased consumption, from 0.160 DID in 2017 to 0.238 DID in 2019, followed by a subsequent drop in consumption with the onset of the COVID-19 pandemic. Oral co-amoxiclav, oral cefuroxime, oral azithromycin and oral co-trimoxazole were the most highly consumed antibiotics. The hospital started off as the higher consumer of antibiotics, but this changed to the community. The consumption of ‘Watch’ group antibiotics increased from 2017 to 2021, with a drop in consumption of ‘Access’ antibiotics and at the onset of COVID-19. Consumption of oral azithromycin was higher in 2021 than 2020. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/222971 Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-12 2079-6382 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/222971 |
identifier_str_mv |
Nagassar, Rajeev P.; Jalim, Narin; Mitchell, Arianne; Harrinanan, Ashley; Mohammed, Anisa; et al.; Antimicrobial Consumption from 2017 to 2021 in East Trinidad and Tobago: A Study in the English-Speaking Caribbean; MDPI; Antibiotics; 12; 3; 2-2023; 1-12 2079-6382 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.3390/antibiotics12030466 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613618961743872 |
score |
13.070432 |